Research resource : modulators of glucocorticoid receptor activity identified by a new high-throughput screening assay
Glucocorticoid steroids affect almost every type of tissue and thus are widely used to treat a variety of human pathological conditions. However, the severity of numerous side effects limits the frequency and duration of glucocorticoid treatments. Of the numerous approaches to control off-target responses to glucocorticoids, small molecules and pharmaceuticals offer several advantages. Here we describe a new, extended high-throughput screen in intact cells to identify small molecule modulators of dexamethasone-induced glucocorticoid receptor (GR) transcriptional activity. The novelty of this assay is that it monitors changes in both GR maximal activity (A(max)) and EC(50) (the position of the dexamethasone dose-response curve). Upon screening 1280 chemicals, 10 with the greatest changes in the absolute value of A(max) or EC(50) were selected for further examination. Qualitatively identical behaviors for 60% to 90% of the chemicals were observed in a completely different system, suggesting that other systems will be similarly affected by these chemicals. Additional analysis of the 10 chemicals in a recently described competition assay determined their kinetically defined mechanism and site of action. Some chemicals had similar mechanisms of action despite divergent effects on the level of the GR-induced product. These combined assays offer a straightforward method of identifying numerous new pharmaceuticals that can alter GR transactivation in ways that could be clinically useful.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Molecular endocrinology (Baltimore, Md.) - 28(2014), 7 vom: 17. Juli, Seite 1194-206 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Blackford, John A [VerfasserIn] |
---|
Links: |
---|
Themen: |
147336-22-9 |
---|
Anmerkungen: |
Date Completed 16.04.2015 Date Revised 21.10.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1210/me.2014-1069 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM238457168 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM238457168 | ||
003 | DE-627 | ||
005 | 20231224113830.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1210/me.2014-1069 |2 doi | |
028 | 5 | 2 | |a pubmed24n0794.xml |
035 | |a (DE-627)NLM238457168 | ||
035 | |a (NLM)24850414 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Blackford, John A |c Jr |e verfasserin |4 aut | |
245 | 1 | 0 | |a Research resource |b modulators of glucocorticoid receptor activity identified by a new high-throughput screening assay |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.04.2015 | ||
500 | |a Date Revised 21.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Glucocorticoid steroids affect almost every type of tissue and thus are widely used to treat a variety of human pathological conditions. However, the severity of numerous side effects limits the frequency and duration of glucocorticoid treatments. Of the numerous approaches to control off-target responses to glucocorticoids, small molecules and pharmaceuticals offer several advantages. Here we describe a new, extended high-throughput screen in intact cells to identify small molecule modulators of dexamethasone-induced glucocorticoid receptor (GR) transcriptional activity. The novelty of this assay is that it monitors changes in both GR maximal activity (A(max)) and EC(50) (the position of the dexamethasone dose-response curve). Upon screening 1280 chemicals, 10 with the greatest changes in the absolute value of A(max) or EC(50) were selected for further examination. Qualitatively identical behaviors for 60% to 90% of the chemicals were observed in a completely different system, suggesting that other systems will be similarly affected by these chemicals. Additional analysis of the 10 chemicals in a recently described competition assay determined their kinetically defined mechanism and site of action. Some chemicals had similar mechanisms of action despite divergent effects on the level of the GR-induced product. These combined assays offer a straightforward method of identifying numerous new pharmaceuticals that can alter GR transactivation in ways that could be clinically useful | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Intramural | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a Receptors, Glucocorticoid |2 NLM | |
650 | 7 | |a Green Fluorescent Proteins |2 NLM | |
650 | 7 | |a 147336-22-9 |2 NLM | |
650 | 7 | |a Dexamethasone |2 NLM | |
650 | 7 | |a 7S5I7G3JQL |2 NLM | |
700 | 1 | |a Brimacombe, Kyle R |e verfasserin |4 aut | |
700 | 1 | |a Dougherty, Edward J |e verfasserin |4 aut | |
700 | 1 | |a Pradhan, Madhumita |e verfasserin |4 aut | |
700 | 1 | |a Shen, Min |e verfasserin |4 aut | |
700 | 1 | |a Li, Zhuyin |e verfasserin |4 aut | |
700 | 1 | |a Auld, Douglas S |e verfasserin |4 aut | |
700 | 1 | |a Chow, Carson C |e verfasserin |4 aut | |
700 | 1 | |a Austin, Christopher P |e verfasserin |4 aut | |
700 | 1 | |a Simons, S Stoney |c Jr |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular endocrinology (Baltimore, Md.) |d 1989 |g 28(2014), 7 vom: 17. Juli, Seite 1194-206 |w (DE-627)NLM01259444X |x 1944-9917 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2014 |g number:7 |g day:17 |g month:07 |g pages:1194-206 |
856 | 4 | 0 | |u http://dx.doi.org/10.1210/me.2014-1069 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2014 |e 7 |b 17 |c 07 |h 1194-206 |